Does OLAPARIB Cause Metastases to lymph nodes? 105 Reports in FDA Database
Prostate Health & Male Vitality — Naturally
ProstaVive: better flow, better sleep, better energy. 180-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 105 reports of Metastases to lymph nodes have been filed in association with OLAPARIB (Lynparza). This represents 0.6% of all adverse event reports for OLAPARIB.
105
Reports of Metastases to lymph nodes with OLAPARIB
0.6%
of all OLAPARIB reports
20
Deaths
24
Hospitalizations
How Dangerous Is Metastases to lymph nodes From OLAPARIB?
Of the 105 reports, 20 (19.0%) resulted in death, 24 (22.9%) required hospitalization, and 11 (10.5%) were considered life-threatening.
Is Metastases to lymph nodes Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OLAPARIB. However, 105 reports have been filed with the FAERS database.
What Other Side Effects Does OLAPARIB Cause?
Death (4,378)
Malignant neoplasm progression (1,862)
Nausea (1,582)
Anaemia (1,455)
Fatigue (1,437)
Off label use (777)
Vomiting (642)
Drug ineffective (563)
Diarrhoea (514)
Asthenia (491)
What Other Drugs Cause Metastases to lymph nodes?
LETROZOLE (436)
DOCETAXEL (404)
CAPECITABINE (370)
PACLITAXEL (352)
TRASTUZUMAB (351)
FULVESTRANT (347)
CYCLOPHOSPHAMIDE (289)
RIBOCICLIB (276)
EVEROLIMUS (273)
TAMOXIFEN (244)
Which OLAPARIB Alternatives Have Lower Metastases to lymph nodes Risk?
OLAPARIB vs OLARATUMAB
OLAPARIB vs OLECLUMAB
OLAPARIB vs OLIVE OIL\SOYBEAN OIL
OLAPARIB vs OLMESARTAN
OLAPARIB vs OLMESARTAN MEDOXOMIL